Meet the leaders who shepherded science through a challenging year
 
Take a moment to think back to March, 2020, a little over a year ago. The World Health Organization had just declared COVID-19 a pandemic. People running research institutes across the world were scrambling to gather information while crafting plans and making decisions that would impact the future of science.
 
In this episode of Lab in the Time of Coronavirus, we sat down with three leaders and administrators tasked with piloting the Zuckerman Institute through the storm. Join us for a behind-the-scenes peek at the balancing act they faced as the world locked down: trying to keep scientists safe while keeping facilities running to prevent years of research from disappearing. Learn about how the crisis surfaced issues of equity while offering up new models for organizing communities in science.

<description>&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Meet the leaders who shepherded science through a challenging year&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Take a moment to think back to March, 2020, a little over a year ago. The World Health Organization had just declared COVID-19 a pandemic. People running research institutes across the world were scrambling to gather information while crafting plans and making decisions that would impact the future of science.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;In this episode of Lab in the Time of Coronavirus, we sat down with three leaders and administrators tasked with piloting the Zuckerman Institute through the storm. Join us for a behind-the-scenes peek at the balancing act they faced as the world locked down: trying to keep scientists safe while keeping facilities running to prevent years of research from disappearing. Learn about how the crisis surfaced issues of equity while offering up new models for organizing communities in science.&lt;/p&gt;
</description>

 
Meet the leaders who shepherded science through a challenging year
 
Take a moment to think back to March, 2020, a little over a year ago. The World Health Organization had just declared COVID-19 a pandemic. People running research institutes acros...

 
Meet the leaders who shepherded science through a challenging year
 
Take a moment to think back to March, 2020, a little over a year ago. The World Health Organization had just declared COVID-19 a pandemic. People running research institutes across the world were scrambling to gather information while crafting plans and making decisions that would impact the future of science.
 
In this episode of Lab in the Time of Coronavirus, we sat down with three leaders and administrators tasked with piloting the Zuckerman Institute through the storm. Join us for a behind-the-scenes peek at the balancing act they faced as the world locked down: trying to keep scientists safe while keeping facilities running to prevent years of research from disappearing. Learn about how the crisis surfaced issues of equity while offering up new models for organizing communities in science.

One Year In

Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist <a href='https://zuckermaninstitute.columbia.edu/barry-honig-phd'>Barry Honig, PhD</a>, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.
 
In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19.

<description>&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist &lt;a href='https://zuckermaninstitute.columbia.edu/barry-honig-phd'&gt;Barry Honig, PhD&lt;/a&gt;, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19. &lt;/p&gt;
</description>


Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in...


Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.
 
In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19. 

Building a Better Antibody

Researchers recruit New Yorkers who have recovered from coronavirus to be scanned for long-term damage to the heart and other organs.
 
So you contracted COVID-19, and you got better. You took an antibody test: It was positive. But do you feel that you've truly recovered?
 
Reports of long-term health problems linked to the coronavirus, from brain fog to hypertension, have been making the news. To better understand the extent of COVID's lasting impacts, researchers at Columbia have launched a study to scan large numbers of survivors for damage.
 
In this episode of Lab in the Time of Coronavirus, join Zuckerman Institute Principal Investigator Tommy Vaughan to explore how scientists are using MRI technology to check the hearts of New Yorkers. And if you want to participate and live in the New York area, <a href='https://recruit.cumc.columbia.edu/clinical_trial/2082'>sign up to see if you're eligible today</a>.

<description>&lt;p&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Researchers recruit New Yorkers who have recovered from coronavirus to be scanned for long-term damage to the heart and other organs.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;So you contracted COVID-19, and you got better. You took an antibody test: It was positive. But do you feel that you've truly recovered?&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Reports of long-term health problems linked to the coronavirus, from brain fog to hypertension, have been making the news. To better understand the extent of COVID's lasting impacts, researchers at Columbia have launched a study to scan large numbers of survivors for damage.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;In this episode of Lab in the Time of Coronavirus, join Zuckerman Institute Principal Investigator Tommy Vaughan to explore how scientists are using MRI technology to check the hearts of New Yorkers. And if you want to participate and live in the New York area, &lt;a href='https://recruit.cumc.columbia.edu/clinical_trial/2082'&gt;sign up to see if you're eligible today&lt;/a&gt;. &lt;/p&gt;
</description>


 
Researchers recruit New Yorkers who have recovered from coronavirus to be scanned for long-term damage to the heart and other organs.
 
So you contracted COVID-19, and you got better. You took an antibody test: It was positive. But do you feel tha...


 
Researchers recruit New Yorkers who have recovered from coronavirus to be scanned for long-term damage to the heart and other organs.
 
So you contracted COVID-19, and you got better. You took an antibody test: It was positive. But do you feel that you've truly recovered?
 
Reports of long-term health problems linked to the coronavirus, from brain fog to hypertension, have been making the news. To better understand the extent of COVID's lasting impacts, researchers at Columbia have launched a study to scan large numbers of survivors for damage.
 
In this episode of Lab in the Time of Coronavirus, join Zuckerman Institute Principal Investigator Tommy Vaughan to explore how scientists are using MRI technology to check the hearts of New Yorkers. And if you want to participate and live in the New York area, sign up to see if you're eligible today. 

Uncovering the Lingering Health Effects of COVID

What does it look like to start graduate school in the middle of a pandemic? In this episode, meet incoming students at Columbia’s Doctoral Program in Neurobiology and Behavior and at the Zuckerman Institute. These young minds are navigating safety concerns and immigration policies while preparing to begin their careers in science: from Francisco Sacudura, who studies how the brain controls the body, to Rachel Frazer, who hopes to explore music and the brain. And they’re getting help, from older students opening up lines of communication and from the co-directors of the doctoral program, <a href='https://www.biology.columbia.edu/people/kelley'>Darcy Kelley, PhD</a>, and <a href='https://grueberlab.neuroscience.columbia.edu/people/wes-grueber'>Wes Grueber, PhD</a>, who are adapting to these difficult times.

<description>&lt;p&gt;&lt;/p&gt;
&lt;p&gt;What does it look like to start graduate school in the middle of a pandemic? In this episode, meet incoming students at Columbia’s Doctoral Program in Neurobiology and Behavior and at the Zuckerman Institute. These young minds are navigating safety concerns and immigration policies while preparing to begin their careers in science: from Francisco Sacudura, who studies how the brain controls the body, to Rachel Frazer, who hopes to explore music and the brain. And they’re getting help, from older students opening up lines of communication and from the co-directors of the doctoral program, &lt;a href='https://www.biology.columbia.edu/people/kelley'&gt;Darcy Kelley, PhD&lt;/a&gt;, and &lt;a href='https://grueberlab.neuroscience.columbia.edu/people/wes-grueber'&gt;Wes Grueber, PhD&lt;/a&gt;, who are adapting to these difficult times.&lt;/p&gt;
</description>


What does it look like to start graduate school in the middle of a pandemic? In this episode, meet incoming students at Columbia’s Doctoral Program in Neurobiology and Behavior and at the Zuckerman Institute. These young minds are navigating safety ...


What does it look like to start graduate school in the middle of a pandemic? In this episode, meet incoming students at Columbia’s Doctoral Program in Neurobiology and Behavior and at the Zuckerman Institute. These young minds are navigating safety concerns and immigration policies while preparing to begin their careers in science: from Francisco Sacudura, who studies how the brain controls the body, to Rachel Frazer, who hopes to explore music and the brain. And they’re getting help, from older students opening up lines of communication and from the co-directors of the doctoral program, Darcy Kelley, PhD, and Wes Grueber, PhD, who are adapting to these difficult times.

Back To School

You’re a graduate student. You’ve spent five to seven years in the lab, doing experiments and analyzing data. At last, the big day comes to present your PhD research, defend your written thesis and get your degree.
 
Then COVID breaks out.
 
Tune in to hear the stories of four women who gave one of the biggest presentations of their lives, their thesis defense, over Zoom. Follow them as they prepared their bedrooms and their basements, grappled with technical issues and discovered surprising advantages to defending online.

<description>&lt;p&gt;&lt;/p&gt;
&lt;p&gt;You’re a graduate student. You’ve spent five to seven years in the lab, doing experiments and analyzing data. At last, the big day comes to present your PhD research, defend your written thesis and get your degree.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Then COVID breaks out.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Tune in to hear the stories of four women who gave one of the biggest presentations of their lives, their thesis defense, over Zoom. Follow them as they prepared their bedrooms and their basements, grappled with technical issues and discovered surprising advantages to defending online.&lt;/p&gt;
</description>


You’re a graduate student. You’ve spent five to seven years in the lab, doing experiments and analyzing data. At last, the big day comes to present your PhD research, defend your written thesis and get your degree.
 
Then COVID breaks out.
 
Tune in...


You’re a graduate student. You’ve spent five to seven years in the lab, doing experiments and analyzing data. At last, the big day comes to present your PhD research, defend your written thesis and get your degree.
 
Then COVID breaks out.
 
Tune in to hear the stories of four women who gave one of the biggest presentations of their lives, their thesis defense, over Zoom. Follow them as they prepared their bedrooms and their basements, grappled with technical issues and discovered surprising advantages to defending online.

Digital Defense

Across the world, scientific laboratories are ramping down in the face of COVID-19. At Columbia University’s Zuckerman Institute, some brain scientists are pivoting from their own research and launching new efforts to combat the novel coronavirus. Lab in the Time of Coronavirus explores these projects and the daily lives of the researchers behind them.

Lab in the Time of Coronavirus

Details

Recent Episodes